Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. | Cost Effectiveness and Resource Allocation BioMed Central Research Formulas for estimating the costs averted by sexually transmitted infection STI prevention programs in the United States Harrell W Chesson Dayne Collins and Kathryn Koski Open Access Address Division of STD Prevention National Center for HIV AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention Atlanta Georgia USA Email Harrell W Chesson - hbc7@ Dayne Collins - DCollins@ Kathryn Koski - KKoski@ Corresponding author Published 23 May 2008 Received 7 September 2007 Cost Effectiveness and Resource Allocation 2008 6 10 doi 1478-7547-6-10 Accepted 23 May 2008 This article is available from http content 6 1 10 2008 Chesson et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Sexually transmitted infection STI prevention programs can mitigate the health and economic burden of STIs. A tool to estimate the economic benefits of STI programs could prove useful to STI program personnel. Methods We developed formulas that can be applied to estimate the direct medical costs and indirect costs lost productivity averted by STI programs in the United States. Costs and probabilities for these formulas were based primarily on published studies. Results We present a series of formulas that can be used to estimate the economic benefits of STI prevention in 2006 US dollars using data routinely collected by STI programs. For example the averted sequelae costs associated with treating women for chlamydia is given as Cw l 995 where Cw is the number of infected women treated for chlamydia is the absolute reduction in the probability of pelvic inflammatory
